Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Fiona McDonald"'
Autor:
Sumeet Hindocha, Des Campbell, Merina Ahmed, Kyriaki Giorgakoudi, Bhupinder Sharma, Nadia Yousaf, Philip Molyneaux, Benjamin Hunter, Hardeep Kalsi, Wanyuan Cui, Michael Davidson, Jaishree Bhosle, Anna Minchom, Imogen Locke, Fiona McDonald, Mary O'Brien, Sanjay Popat, Richard W. Lee
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Pneumonitis is a well-described, potentially life-threatening adverse effect of immune checkpoint inhibitors (ICI) and thoracic radiotherapy. It can require additional investigations, treatment, and interruption of cancer therapy. It is important for
Externí odkaz:
https://doaj.org/article/d7fc4751a1704cf7bbb0ec2d47b86ad1
Autor:
Nicolas, Girard, Jair, Bar, Pilar, Garrido, Marina C, Garassino, Fiona, McDonald, Françoise, Mornex, Andrea R, Filippi, Hans J M, Smit, Solange, Peters, John K, Field, Daniel C, Christoph, Anne, Sibille, Rainer, Fietkau, Vilde D, Haakensen, Christos, Chouaid, Ben, Markman, T Jeroen N, Hiltermann, Alvaro, Taus, William, Sawyer, Allison, Allen, Pratibha, Chander, Muriel, Licour, Benjamin, Solomon
Publikováno v:
Journal of thoracic oncology, vol. 18, no. 2, pp. 181-193
Journal of Thoracic Oncology, 18(2), 181-193. ELSEVIER SCIENCE INC
Journal of Thoracic Oncology, 18(2), 181-193. ELSEVIER SCIENCE INC
Introduction: The phase 3 PACIFIC trial established consolidation therapy with durvalumab as standard of care for patients with unresectable, stage III NSCLC and no disease progression after definitive chemoradiotherapy (CRT). The observational PACIF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e3e9cc938d1b0b5c469ec7715413b7
https://serval.unil.ch/notice/serval:BIB_D36FA0602240
https://serval.unil.ch/notice/serval:BIB_D36FA0602240
Publikováno v:
British Journal of Cancer
The treatment paradigm of non-small-cell lung cancer (NSCLC) has rapidly changed in recent years following the introduction of immune-checkpoint inhibition (ICI). Pre-clinically, both chemotherapy and radiotherapy modulate the tumour microenvironment
Autor:
Joan N. Kyula, Gabriella Baker, David Mansfield, Matthew Chiu, Anna Wilkins, Kevin J. Harrington, Eva Crespo-Rodriguez, Edward Armstrong, Alan Melcher, Martin McLaughlin, Fiona McDonald, Vicki Jennings, Victoria Roulstone, Shane Foo, Malin Pedersen, Galabina Bozhanova, Lorna Grove, Emmanuel C Patin
Publikováno v:
Expert Opinion on Biological Therapy. 20:635-652
Introduction: Immune checkpoint inhibitors (ICI) have dramatically improved the outcome for cancer patients across multiple tumor types. However the response rates to ICI monotherapy remain relativ...
Publikováno v:
Putora, Paul Martin; Leskow, Pawel; McDonald, Fiona; Batchelor, Tim; Evison, Matthiew (2020). International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? ERJ Open Research, 6(1) European Respiratory Society 10.1183/23120541.00159-2019
ERJ Open Research, Vol 6, Iss 1 (2020)
ERJ Open Research
ERJ Open Research, Vol 6, Iss 1 (2020)
ERJ Open Research
Stage III N2 nonsmall cell lung cancer (NSCLC) is a complex disease with poor treatment outcomes. For patients in whom the disease is considered technically resectable, the main treatment options include surgery (with neoadjuvant or adjuvant chemothe
Autor:
Sumeet Hindocha, Des Campbell, Merina Ahmed, Kyriaki Giorgakoudi, Bhupinder Sharma, Nadia Yousaf, Philip Molyneaux, Benjamin Hunter, Hardeep Kalsi, Wanyuan Cui, Michael Davidson, Jaishree Bhosle, Anna Minchom, Imogen Locke, Fiona McDonald, Mary O'Brien, Sanjay Popat, Richard W. Lee
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine, Vol 8 (2021)
Pneumonitis is a well-described, potentially life-threatening adverse effect of immune checkpoint inhibitors (ICI) and thoracic radiotherapy. It can require additional investigations, treatment, and interruption of cancer therapy. It is important for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bb7843d679a7c462abd95bab28865f
http://hdl.handle.net/10044/1/92612
http://hdl.handle.net/10044/1/92612
Autor:
Fiona McDonald, Timothy J.P. Batchelor, Neal Navani, Paul Van Schil, Sanjay Popat, Suresh Senan, Egbert F. Smit, Keith M. Kerr
Publikováno v:
E315
E306
Popat, S, Navani, N, Kerr, K M, Smit, E F, Batchelor, T J P, van Schil, P, Senan, S & McDonald, F 2021, ' Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach ', The Oncologist, vol. 26, no. 2, pp. e306-e315 . https://doi.org/10.1002/onco.13586, https://doi.org/10.1002/onco.13586
The oncologist
The Oncologist, 26(2), e306-e315. AlphaMed Press
The Oncologist, e306-e315. WILEY
STARTPAGE=e306;ENDPAGE=e315;TITLE=The Oncologist
The Oncologist
E306
Popat, S, Navani, N, Kerr, K M, Smit, E F, Batchelor, T J P, van Schil, P, Senan, S & McDonald, F 2021, ' Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach ', The Oncologist, vol. 26, no. 2, pp. e306-e315 . https://doi.org/10.1002/onco.13586, https://doi.org/10.1002/onco.13586
The oncologist
The Oncologist, 26(2), e306-e315. AlphaMed Press
The Oncologist, e306-e315. WILEY
STARTPAGE=e306;ENDPAGE=e315;TITLE=The Oncologist
The Oncologist
Non‐small cell lung cancer (NSCLC) accounts for approximately one in five cancer‐related deaths, and management requires increasingly complex decision making by health care professionals. Many centers have therefore adopted a multidisciplinary ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d79e1986bef730d80657e968caf3bc
http://hdl.handle.net/10044/1/88255
http://hdl.handle.net/10044/1/88255
Autor:
Urska Janzic, Anna Minchom, Naila Kaudeer, Simon Page, C. Milner-Watts, Jaishree Bhosle, Liam Welsh, I. Locke, Merina Ahmed, Natalia Vidal, Mary O'Brien, Marco Perna, Fiona McDonald
Publikováno v:
European journal of cancer (Oxford, England : 1990). 132
Brain metastases (BrMs) are associated with significant morbidity and are found in up to 50% of patients with advanced non-small cell lung cancer (NSCLC). Most of the literature focuses on symptomatic BrMs, with a lack of baseline brain imaging in as
Autor:
Corinne Faivre-Finn, Fiona McDonald, Michèle De Waele, Lizza E.L. Hendriks, Anne-Marie C. Dingemans, Paul Van Schil
Publikováno v:
McDonald, F, De Waele, M, Hendriks, L E L, Faivre-Finn, C, Dingemans, A-M C & Van Schil, P E 2017, ' Management of stage I and II nonsmall cell lung cancer ', European Respiratory Journal, vol. 49, no. 1 . https://doi.org/10.1183/13993003.00764-2016
European Respiratory Journal, 49(1). European Respiratory Society
The European respiratory journal
European Respiratory Journal, 49(1). European Respiratory Society
The European respiratory journal
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing population and introduction of screening for high-risk individuals. Optimal management requires multidisciplinary collaboration. Local treatments include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad19fd9ae7cdc158c8807c1b139e0e1
https://doi.org/10.1183/13993003.00764-2016
https://doi.org/10.1183/13993003.00764-2016
Publikováno v:
Harrow, S, Hanna, G G, Faivre-Finn, C, McDonald, F & Chalmers, A J 2016, ' The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer ', Clinical Oncology, vol. 28, no. 11, pp. 720-725 . https://doi.org/10.1016/j.clon.2016.08.004
Harrow, S, Hanna, G, Faivre-Finn, C, McDonald, F & Chalmers, A J 2016, ' The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer ', Clinical oncology (Royal College of Radiologists (Great Britain)), vol. 28, no. 11, pp. 720-725 . https://doi.org/10.1016/j.clon.2016.08.004
Harrow, S, Hanna, G, Faivre-Finn, C, McDonald, F & Chalmers, A J 2016, ' The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer ', Clinical oncology (Royal College of Radiologists (Great Britain)), vol. 28, no. 11, pp. 720-725 . https://doi.org/10.1016/j.clon.2016.08.004
Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ea46918d82a36869266c3b0f853922
https://eprints.gla.ac.uk/128261/1/128261.pdf
https://eprints.gla.ac.uk/128261/1/128261.pdf